U.S. bill to restrict WuXi AppTec, other Chinese biotech cos revised to give more time to cut ties

WuXi Biologics (Cayman)

10/05/2024 15:34

By Karen Freifeld
       May 10 (Reuters) - A new version of a bill that would
restrict U.S. business with China's WuXi AppTec, BGI and other
biotechnology companies of concern would allow companies until
2032 to end work with the Chinese firms, extending the amount of
time to find new partners.
    The latest Biosecure Act also adds WuXi Biologics to a list
of biotech companies of concern. The other companies on the list
are BGI, MGI, Complete Genomics and WuXi AppTec.
    The bill will be introduced on Friday and a U.S. House of
Representatives committee is expected to decide next week
whether to move the bill forward, according to a House Committee
on Oversight and Accountability spokesperson. The markup,
expected Wednesday, is a procedural step in the process to the
bill's possibly becoming law. A similar Senate bill was approved
by a committee there in March

 (Reporting by Karen Freifeld; Editing by Chizu Nomiyama)
 ((karen.freifeld@thomsonreuters.com; +1(646) 223-6921;))